441 related articles for article (PubMed ID: 17207027)
1. Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis.
Reid DW; Misso N; Aggarwal S; Thompson PJ; Walters EH
Respirology; 2007 Jan; 12(1):63-9. PubMed ID: 17207027
[TBL] [Abstract][Full Text] [Related]
2. Exhaled cysteinyl-leukotrienes and 8-isoprostane in patients with asthma and their relation to clinical severity.
Samitas K; Chorianopoulos D; Vittorakis S; Zervas E; Economidou E; Papatheodorou G; Loukides S; Gaga M
Respir Med; 2009 May; 103(5):750-6. PubMed ID: 19110408
[TBL] [Abstract][Full Text] [Related]
3. Leukotrienes and 8-isoprostane in exhaled breath condensate of children with stable and unstable asthma.
Zanconato S; Carraro S; Corradi M; Alinovi R; Pasquale MF; Piacentini G; Zacchello F; Baraldi E
J Allergy Clin Immunol; 2004 Feb; 113(2):257-63. PubMed ID: 14767439
[TBL] [Abstract][Full Text] [Related]
4. Sputum eicosanoid profiling in exacerbations of chronic obstructive pulmonary disease.
Drozdovszky O; Barta I; Antus B
Respiration; 2014; 87(5):408-15. PubMed ID: 24714447
[TBL] [Abstract][Full Text] [Related]
5. Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy.
Colombo C; Costantini D; Rocchi A; Cariani L; Garlaschi ML; Tirelli S; Calori G; Copreni E; Conese M
Pediatr Pulmonol; 2005 Jul; 40(1):15-21. PubMed ID: 15858808
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 and cysteinyl leukotriene concentrations in sputum: association with asthma severity and eosinophilic inflammation.
Aggarwal S; Moodley YP; Thompson PJ; Misso NL
Clin Exp Allergy; 2010 Jan; 40(1):85-93. PubMed ID: 19895589
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation.
Lagrange-Puget M; Durieu I; Ecochard R; Abbas-Chorfa F; Drai J; Steghens JP; Pacheco Y; Vital-Durand D; Bellon G
Pediatr Pulmonol; 2004 Jul; 38(1):43-9. PubMed ID: 15170872
[TBL] [Abstract][Full Text] [Related]
8. Production of the potent neutrophil chemokine, growth-related protein alpha (GROalpha), is not elevated in cystic fibrosis children.
Wyatt HA; Sampson AP; Balfour-Lynn IM; Price JF
Respir Med; 2000 Feb; 94(2):106-11. PubMed ID: 10714414
[TBL] [Abstract][Full Text] [Related]
9. Inhaled glutathione decreases PGE2 and increases lymphocytes in cystic fibrosis lungs.
Hartl D; Starosta V; Maier K; Beck-Speier I; Rebhan C; Becker BF; Latzin P; Fischer R; Ratjen F; Huber RM; Rietschel E; Krauss-Etschmann S; Griese M
Free Radic Biol Med; 2005 Aug; 39(4):463-72. PubMed ID: 16043018
[TBL] [Abstract][Full Text] [Related]
10. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
Sagel SD; Kapsner RK; Osberg I
Pediatr Pulmonol; 2005 Mar; 39(3):224-32. PubMed ID: 15635615
[TBL] [Abstract][Full Text] [Related]
11. Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction.
Carraro S; Corradi M; Zanconato S; Alinovi R; Pasquale MF; Zacchello F; Baraldi E
J Allergy Clin Immunol; 2005 Apr; 115(4):764-70. PubMed ID: 15805996
[TBL] [Abstract][Full Text] [Related]
12. Exhaled 8-isoprostane and prostaglandin E(2) in patients with stable and unstable cystic fibrosis.
Lucidi V; Ciabattoni G; Bella S; Barnes PJ; Montuschi P
Free Radic Biol Med; 2008 Sep; 45(6):913-9. PubMed ID: 18634869
[TBL] [Abstract][Full Text] [Related]
13. Intranasal steroid reduces exhaled bronchial cysteinyl leukotrienes in allergic patients.
Failla M; Biondi G; Provvidenza Pistorio M; Gili E; Mastruzzo C; Vancheri C; Crimi N
Clin Exp Allergy; 2006 Mar; 36(3):325-30. PubMed ID: 16499643
[TBL] [Abstract][Full Text] [Related]
14. Cellular proteolysis and systemic inflammation during exacerbation in cystic fibrosis.
Ionescu AA; Nixon LS; Shale DJ
J Cyst Fibros; 2004 Dec; 3(4):253-8. PubMed ID: 15698944
[TBL] [Abstract][Full Text] [Related]
15. Markers of airway inflammation in primary ciliary dyskinesia studied using exhaled breath condensate.
Zihlif N; Paraskakis E; Tripoli C; Lex C; Bush A
Pediatr Pulmonol; 2006 Jun; 41(6):509-14. PubMed ID: 16617444
[TBL] [Abstract][Full Text] [Related]
16. Glycosylation of sputum mucins is altered in cystic fibrosis patients.
Schulz BL; Sloane AJ; Robinson LJ; Prasad SS; Lindner RA; Robinson M; Bye PT; Nielson DW; Harry JL; Packer NH; Karlsson NG
Glycobiology; 2007 Jul; 17(7):698-712. PubMed ID: 17392389
[TBL] [Abstract][Full Text] [Related]
17. The effect of treatment of cystic fibrosis pulmonary exacerbations on airways and systemic inflammation.
Downey DG; Brockbank S; Martin SL; Ennis M; Elborn JS
Pediatr Pulmonol; 2007 Aug; 42(8):729-35. PubMed ID: 17588254
[TBL] [Abstract][Full Text] [Related]
18. Effect of cystic fibrosis exacerbations on neutrophil function.
Brockbank S; Downey D; Elborn JS; Ennis M
Int Immunopharmacol; 2005 Mar; 5(3):601-8. PubMed ID: 15683855
[TBL] [Abstract][Full Text] [Related]
19. Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations.
Baraldi E; Carraro S; Alinovi R; Pesci A; Ghiro L; Bodini A; Piacentini G; Zacchello F; Zanconato S
Thorax; 2003 Jun; 58(6):505-9. PubMed ID: 12775861
[TBL] [Abstract][Full Text] [Related]
20. Recurrent exacerbations affect FEV(1) decline in adult patients with cystic fibrosis.
Amadori A; Antonelli A; Balteri I; Schreiber A; Bugiani M; De Rose V
Respir Med; 2009 Mar; 103(3):407-13. PubMed ID: 19027279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
